Report

The Europe Blister Packaging Market is expected to register a CAGR of 6.45% during the forecast period.

Key Highlights
- Growing pressure on pharmaceutical companies to manufacture medicines that are different in packaging and hard to imitate, surpassing the basic need of keeping it useful for the purpose it was produced, for it to be made available for patients, due to growth in diseases and stringent government regulations against counterfeit drugs, are among the significant factors propelling the market. Blister packaging provides an efficient method of anti-counterfeit systems, like banknote authentication systems and others.
- The UK pharmaceutical industry is one of the major players in the research and innovation of the country. The industry contributes billions on R&D and employs vast numbers for highly-skilled R&D roles. According to the Association of the British Pharmaceutical Industry (ABPI), 23,000 people work in R&D out of 73,000 people employed directly by the pharmaceutical industry.
- The massive investments and the proportion of skilled workers employed show how Britain is building up the pipeline of medicines and future drugs. These ongoing investments are expected to provide an excellent opportunity for the growth of blister packaging in the country.
- The use of innovative technologies in blisters, such as RFID (radio frequency identification tags), deployed with a seal applied outside the packaging, is increasing due to the potential to offer individual security throughout supply chains. Contamination of samples in blisters only occurs when a single capsule or tablet is dispensed or administered when the protective barrier is broken.
- Furthermore, the outbreak has increased the research across the world for developing a vaccine for COVID-19. For instance, the healthcare giant, Johnson & Johnson, started clinical trials in September 2020 and has received a nearly USD 500 million partnership via a US Department of Health and Human Services division.
- Also, experimental vaccines developed by researchers at the University of Pittsburgh and Baylor College of Medicine in Houston are also waiting for permission from the Food and Drug Administration to begin testing in people. The success of these vaccines developed by the researchers might follow the large-scale manufacture of them, further driving the demand for liquid bottles.


Europe Blister Packaging Market Trends

Pharmaceutical is Expected to Witness a Significant Growth


- The pharmaceutical sector poses a different set of demands for blister packaging solutions, concerning insulation from external surroundings, cost-effectiveness, high levels of protection, and the ease of handling and retaining the effectiveness of the medicine.These packs are uniquely suited to meet stringent regulations and are highly valued for protective properties, cost-effectiveness, adaptability, and the pharmaceutical and packaging industry's requirements.
- When medicines are blister packaged, adherence is improved because consumers can keep track of their medications and dosage. The unit dosage feature of blisters reduces the risk of incorrect dosing.
- The retail-level preparation of prescription drugs is troubling pharmaceutical technicians or pharmacists. The administration of medicines in the open atmosphere of the supermarket and drug store may negatively affect sensitive medicines when they are transferred from container to container. Blister packaging can guarantee the process of distribution directly to the customer.
- Protecting product integrity continues to be the primary goal of pharmaceutical packaging, but there is continued work on cost reduction in the packaging process in all areas of the packaging industry. For instance, The Polybar barrier films product families provided by Amcor cover a wide range of moisture barriers whilst also providing good crush resistance to ensure the best protection for pharmaceutical applications such as tablets and capsules. It uses materials such as Aclar, COC, PE, PVC, and PVdc, among others.
- Further, the outbreak of the COVID-19 has increased the market for blister packaging. In October 2019, the Ukrainian pharmaceutical company Darnitsa passed the state registration for an experimental drug in the treatment protocol for COVID-19.
- A few countries across the region have banned the export of medicines that have shown efficacy in the fight against coronavirus infection, and first and foremost, meet the domestic demand. The Darnitsa pharmaceutical company passed the state registration for hydroxychloroquine substance - an experimental drug that is included in the treatment protocol for COVID-19.


CIS Countries are Expected to WItness SIgnificant Growth


- Among the CIS countries, Russia is anticipated to hold a significant share. The pharmaceutical industry in Russia, one of the Commonwealth of Independent States (CIS) countries, can be considered one of the most complex sectors when considering the management of the intellectual property (IP), as it involves complicated legal, regulatory, linguistic, and marketing factors.
- The country has been witnessing significant growth in drug production. According to the Russian Ministry of Industry and Trade, the Russian government expects a 20% growth of domestic drug production in 2020, which is responsible for developing the pharmaceutical industry in the Russian government.
- According to the Minister, the expected growth will be comparable to that which was observed in the first four months of 2020 and was mainly due to the commissioning of some new production facilities within the country.
- However, the Russian government has also prepared a new strategy - the state program Pharma 2030, which should get the pharmaceutical sector's positive trends. The past decade's results, the expectations for the new program, and the promising areas and locations for investments in pharmaceuticals are mentioned in the Moscow Region Development Corporation (MRDC) material.
- And according to MRDC, in the near future, Russia will start implementing the state strategy of pharmaceutical industry development Pharma 2030. The strategy indicates the main industry directions, the growth of which will be stimulated with the help of the state support mechanisms.
- The state program of the country Pharma 2020 gave a strong impetus for developing the medical and pharmaceutical sectors, particularly at the initial stage of implementation. Industry players can expect a good start from the new state program, which is anticipated to augment the market growth in the CIS region.


Europe Blister Packaging Industry Overview

The market for Europe Blister Packaging Market is moderately fragmented. Partnership, mergers, and acquisitions have been a significant strategy for the vendors in the market for producing acceptable products in the end-user industry, where packaging materials undergo stringent quality tests not to contaminate the contents impact health. Maintaining a continuous flow of raw materials remain a challenge that prompts partnerships. Some of the major players in the market are Amcor Ltd, Westrock Company, Sonoco Products Company, Constantia Flexibles GmbH, Honeywell International Inc., among others.


- April 2021 - Amcor announced customer trials for the recyclable Polyethylene-based thermoform blister packaging. The new packaging is designed to meet the stringent requirements of highly specialized and regulated pharmaceutical packaging and creates a more sustainable alternative for the most in-demand healthcare packaging type. This innovation also benefits from up to 70% reduction in its carbon footprint when compared to packaging alternatives on the market.
- July 2021 - Honeywell and Premier Inc., a leading technology-driven healthcare improvement company, announced a new commercial relationship dedicated to expanding the domestic production of nitrile exam gloves. This new collaboration is expected to produce at least 750 million domestically made nitrile exam gloves in the first year alone.


Additional Benefits:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support